News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

KBI BioPharma Advances Proprietary Bioprocessing Technology Into Applied Biopharmaceutical Development



10/19/2005 5:10:55 PM

KBI BioPharma, Inc., a contract biopharmaceutical process development, production and technology company, today announced the advancement of its proprietary Centrifugal Bioreactor (CBR) technology from a research environment into an applied development phase.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES